CARISOPRODOL
CARISOPRODOL TABLETS. These highlights do not include all the information needed to use CARISOPRODOL TABLETS safely and effectively. See full prescribing information for CARISOPRODOL TABLETS. CARISOPRODOL tablets for oral use, CIV Initial U.S. Approval: 1959
Approved
Approval ID
48a6e3ff-d146-44ef-8ab4-2a5655b7aec2
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 16, 2023
Manufacturers
FDA
Golden State Medical Supply, Inc.
DUNS: 603184490
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
CARISOPRODOL
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code60429-508
Application NumberANDA203374
Product Classification
M
Marketing Category
C73584
G
Generic Name
CARISOPRODOL
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 16, 2023
FDA Product Classification
INGREDIENTS (8)
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94E
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CARISOPRODOLActive
Quantity: 350 mg in 1 1
Code: 21925K482H
Classification: ACTIB